Skip to main content
. 2016 May 9:73–85. doi: 10.1016/B978-0-12-374279-7.19001-0

Table 1.

Endocrine interventions and immunity

Intervention Aim (Side-)effect on immunity References
Oral contraceptives Prevent ovulation Increased risk for genital tract infections
No effect on risk for MS, RA, SLE
Fichorova et al. (2015), Mohllajee et al. (2006), Murphy et al. (2014), and Straub (2007)
In vitro fertilization Induce ovulation, maintain early pregnancy Unknown Huang and Rosenwaks (2012) and Yanushpolsky (2015)
Estrogen replacement therapy Alleviate peri- and postmenopausal symptoms Partial restoration of immunological function seen during reproductive age
Increased symptoms of SLE
Holroyd and Edwards (2009), Giefing-Kroll et al. (2015), and Straub (2007)
Aromatase inhibitors Deprive ER+ breast cancer from estrogens Clinical signs of RA (e.g., joint pain) Zhang et al. (2010)
Androgen replacement therapy Reduction of inflammation in hypogonadism Suppression of cellular and humoral immune responses Cutolo et al. (2002), Kocar et al. (2000), Musabak et al. (2003), Ackerman (2006), Malkin et al. (2004), and Fijak et al. (2011)
CRH antagonists Reduction of excessive glucocorticoid release Reduction of downstream immune-suppression Elenkov et al. (1999) and Zoumakis et al. (2006)

MS, multiple sclerosis; ER; estrogen receptor; RA; rheumatoid arthritis; SLE, systemic lupus erythematosus; CRH, corticotropin-releasing hormone.